Assyro AI

FDA Orange Book · active-ingredient family

Amlexanox

Amlexanox is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:AMLEXANOX · NDA 021727

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · paste, patch

ProductApplicantApplicationTEApproved
AMLEXANOXULURUNDA 021727Sep 29, 2004
APHTHASOLULURUNDA 020511Dec 17, 1996

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amlexanox — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.